Skip to content
Screener
AngioDynamics logo

AngioDynamics

ANGO

AngioDynamics is a medical technology company that designs, manufactures, and sells minimally invasive medical devices for the treatment of cardiovascular disease and cancer.

Market cap
$509.7M-2.3%
Revenue$325.4M+8.2%
Net income-$32.9M-2.6%
EPS (diluted)-$0.78—
Trailing twelve months · change vs. prior year

Earnings

Next report

Jan 6, 2027 (in 2 months)
Revenue estimate$84.3M
EPS estimate-$0.11

Financials

Q1 2027

Income statement

See full
Revenue$80.9M+6.9%
Gross profit$48.0M+14.8%
Operating income-$7.3M+31.5%
Net income-$7.1M+34.9%
EPS (diluted)-$0.17+34.6%

Balance sheet

See full
Cash & equivalents$34.0M-12.4%
Total debt$7.3M+19.0%
Total equity$164.0M-8.3%
Total assets$241.9M-8.9%

Cash flow

See full
Operating cash flow-$15.3M+3.7%
CapEx$379.0K-48.2%
Free cash flow-$15.7M+5.6%

Valuation & ratios

Valuation

See full
Market cap$509.7M-2.3%
Enterprise value$482.98M+2.1%
P/S1.6×-0.1×

Profitability

See full
Gross margin55.7%+1.5pp
Operating margin-11.2%-1.0pp
Net margin-10.1%-0.5pp

Returns & leverage

See full
Return on equity-19.2%+2.7pp
Debt / equity0×0.0×
Current ratio2.4×+0.1×

Segments

By product

See full
Med Device$41.0M+1.4%
Med Tech$39.9M+13.2%

Competitors

Profile

AngioDynamics is a medical technology company that designs, manufactures, and sells minimally invasive medical devices for the treatment of cardiovascular disease and cancer. The company focuses on improving patient outcomes through innovative research and development in vascular access, peripheral vascular disease, and oncology ablation. Its value proposition centers on providing clinicians with high-quality, cost-effective alternatives to traditional surgical procedures.

Competitive position

A diversified player in niche interventional markets, competing through a mix of proprietary high-tech ablation platforms and a broad portfolio of standard interventional supplies.

GeographiesUnited States, European Union, Canada, Japan, Brazil, China
Customer segmentsHospitals, Specialized Medical Clinics, Ambulatory Surgery Centers
Business modelManufacturing, Direct Sales, Distributor-based Sales
SuppliersRaw material suppliers, Contract manufacturers, Electronic component providers, Specialized polymer suppliers
CustomersHospitals, Health systems, Medical distributors, Government healthcare programs
Listed2004
Employees815.0
CEOEric Honroth
FilingsSEC EDGAR

FAQ

What is AngioDynamics's market cap?
AngioDynamics (ANGO) has a market capitalization of $509.7M and trades on NASDAQ.
What is AngioDynamics's revenue and profitability?
AngioDynamics generated $325.4M in trailing twelve-month revenue with a net loss of $32.9M, representing a net margin of -10.1%. Gross margin stands at 55.7%. The latest reported period is Q1 2027.
Who are AngioDynamics's competitors?
AngioDynamics's key competitors include Merit Medical Systems, Inc., Teleflex Medical, Medtronic, and others. These companies compete in similar markets and product categories.
Who does AngioDynamics partner with?
AngioDynamics's notable partners include Biomerics, Medline Industries, Inc., Merit Medical Systems, Inc., and others.
What subsidiaries does AngioDynamics have?
AngioDynamics's subsidiaries include Eximo Medical, Ltd., RadiaDyne.
Where is AngioDynamics headquartered?
AngioDynamics is headquartered in United States of America and employs approximately 815 people. It has been publicly traded since 2004.